Corrigendum to "MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer" [Gynecologic Oncology 110: 13-21, 2008] (DOI:10.1016/j.ygyno.2008.04.033);MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer

Gynecologic Oncology

Volumn 110, Issue 1, 2008, Pages 13-21

  Taylor, Douglas D ^a   Gercel Taylor, Cicek ^a  

^a Department of Obstetrics Gynecology and Women's Health   (United States)

Author keywords

Diagnosis; Exosomes; MicroRNA; Ovarian cancer; Screening

Indexed keywords

MICRORNA; TUMOR MARKER;

ARTICLE; BLOOD SAMPLING; CANCER CELL; CANCER DIAGNOSIS; CANCER PATIENT; CANCER SCREENING; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DNA FINGERPRINTING; EXOSOME; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL;

EID: 45449093192     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2009.10.045     Document Type: Erratum

References (32)

1. Sankaranarayanan R., and Ferlay J. Worldwide burden of gynaecological cancer: the size of the problem. Best Pract Res Clin Obstet & Gynaecol 20 (2006) 207-225
2. Berek J.S., Schultes B.C., and Nicodemus C.F. Biologic and immunologic therapies for ovarian cancer. J Clin Oncol 21 s10 (2003) 168-174
3. Menon U., and Jacobs I.J. Recent developments in ovarian cancer screening. Curr Opin Obstet Gynecol 12 (2000) 39-42
4. Iorio M.V., Visone R., Di Leva G., Donati V., Petrocca F., Casalini P., et al. MicroRNA signatures in human ovarian cancer. Cancer Res 67 (2007) 8699-8707
5. De Cecco L., Marchionni L., Gariboldi M., Reid J.F., Lagonigro M.S., Caramuta S., et al. Gene expression profiling of advanced ovarian cancer: characterization of a molecular signature involving fibroblast growth factor 2. Oncogene 23 (2004) 8171-8183
6. Calin G.A., and Croce C.M. MicroRNA-cancer connection: the beginning of a new tale. Cancer Res 66 (2006) 7390-7394
7. Esquela-Kerscher A., and Slack F.J. Oncomirs - microRNAs with a role in cancer. Nature Rev Cancer 6 (2006) 259-269
8. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116 (2004) 281-297
9. Miska E.A. How microRNAs control cell division, differentiation, and death. Curr Opi Genet Dev 5 (2005) 563-568
10. Calin G.A., and Croce C.M. MicroRNA signatures in human cancers. Nature Rev Cancer 6 (2006) 857-866
11. Lu J., Getz G., Miska E.A., Alvarez-Saavedra E., Lamb J., Peck D., et al. MicroRNA expression profiles classify human cancers. Nature 435 (2005) 834-838
12. Zhang L., Huang J., Yang N., et al. microRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci USA 103 (2006) 9136-9141
13. Taylor D.D., and Doellgast G.J. Quantitation of eroxidise-antibody binding to membrane fragments using column chromatography. Anal Biochem 98 (1979) 53-59
14. Taylor D.D., Homesley H.D., and Doellgast G.J. Binding of specific peroxidise-labeled antibody to placental-type alkaline phospohatase on tumor-derived membrane fragments. Cancer Res 40 (1980) 4964-4969
15. Raposo G., Tenza D., Mecheri S., Peronet R., Bonnerot C., and Desaymard C. Accumulation of major histocompatibility complex class II molecules in mast cell secretory granules and their release upon degranulation. Mol Biol Cell 8 (1997) 2631-2645
16. Heijnen H.F.G., Schiel A.E., Fijnheer R., Geuze H.J., and Sixma J.J. Activation platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha granules. Blood 94 (1999) 3791-3799
17. Taylor D.D., and Black P.H. Shedding of plasma membrane fragments: Neoplastic and developmental importance. In: Steinberg M. (Ed). Developmental Biology vol. 3 (1986) 33-57
18. Taylor D.D., Bohler H.C., and Gercel-Taylor C. Pregnancy-linked suppression of TcR signaling pathways by a circulating factor absent in recurrent spontaneous pregnancy loss. Molecular Immunology 43 (2006) 1872-1880
19. Sabapatha A., Gercel-Taylor C., and Taylor D.D. Specific isolation of placental-derived exosomes from the circulation of pregnant women and their immunoregulatory consequences. Am J Reprod Immunol 56 (2006) 345-355
20. Taylor D.D., and Gercel-Taylor C. Tumour-derived exosomes as mediates of T-cell signaling defects. Brit J Cancer 92 (2005) 305-311
21. Olver C., and Vidal M. Proteomic analysis of secreted exosomes. Subcell Biochem 43 (2007) 99-131
22. Mears R., Craven R.A., Hanrahan S., et al. Proteomic analysis of melanoma-derived exosomes by two-dimensional polyacrylamide gel electrophoresis and mass spectrometry. Proteomics 4 (2004) 4019-4031
23. Bard M.P., Hegmans J.P., Hemmes A., et al. Proteomic analysis of exosomes isolated from human malignant pleural effusions. Am J Respir Cell Mol Biol 31 (2004) 114-121
24. Choi D.S., Lee J.M., Park G.W., et al. Proteomic analysis of microvesicles derived from human colorectal cancer cells. J Proteome Res 6 (2007) 4646-4655
25. Escola J.M., Kleijmeer M.J., Stoorvogel W., Griffith J.M., Yoshie O., and Geuze H.J. Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B-lymphocytes. J Biol Chem 273 (1998) 20121-20127
26. Andre F., Schartz N.E., Movassagh M., et al. Malignant effusions and immunogenic tumour-derived exosomes. Lancet 360 (2002) 295-305
27. Valenti R., Huber V., Filipazzi P., Pilla L., Sovena G., Villa A., et al. Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-beta-mediated suppressive activity on T lymphocytes. Cancer Res 66 (2006) 9290-9298
28. Koga K., Matsumoto K., Akiyoshi T., Kubo M., et al. Purification, characterization and biological significance of tumor-derived exosomes. Anticancer Res 25 (2005) 3703-3707
29. Ratajczak J., Miekus K., Kucia M., et al. Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia 20 (2006) 847-856
30. Valadi H., Ekstrom K., Bossius A., Sjostrand M., Lee J.J., and Lotvall J.O. Exosome-mediated transfer of mRNA and microRNA is a novel mechanism of genetic exchange. Nature Cell Biol 9 (2007) 652-659
31. Yang H., Kong W., He L., Zhao J.J., O'Donnell J.D., Wang J., et al. MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res 68 (2008) 425-433
32. Paul E., Blower P.E., Chung J.H., Verducci J.S., Lin S., Park J.K., et al. MicroRNAs modulate the chemosensitivity of tumor cells. Mol Cancer Therap 7 (2008) 1-9